Is there an association between selective serotonin reuptake inhibitors and risk of abnormal bleeding? Results from a cohort study based on prescription event monitoring in England.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  European Journal of Clinical Pharmacology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 11417450
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of 5-hydroxytryptamine uptake in human platelets by antidepressant agents in vivo

  2004cited by this paper
• Terminology in prescription-event monitoring

  2004cited by this paper
• The influence of age and sex on the prevalence of depressive conditions: report from the National Survey of Psychiatric Morbidity

  2003cited by this paper
• Intracranial haemorrhage and use of selective serotonin reuptake inhibitors.

  2000cited by this paper
• Antidepressants and upper gastrointestinal bleeding

  1999cited by this paper
• Comparison of the Effects of Antidepressants and Their Metabolites on Reuptake of Biogenic Amines and on Receptor Binding

  1999cited by this paper
• Systematic Review and Guide to Selection of Selective Serotonin Reuptake Inhibitors

  1999cited by this paper
• Management of uninvestigated and functional dyspepsia: a working party report for the World Congresses of Gastroenterology 1998

  1999cited by this paper
• Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study

  1999cited by this paper
• Underreporting of suspected adverse drug reactions to newly marketed (“black triangle”) drugs in general practice: observational study

  1998cited by this paper
• Spontaneous ecchymoses due to paroxetine administration.

  1998cited by this paper
• 5-Hydroxytryptamine2-family receptors (5-hydroxytryptamine2A, 5-hydroxytryptamine2B, 5-hydroxytryptamine2C): where structure meets function.

  1998cited by this paper
• General practitioners' perceptions of the tolerability of antidepressant drugs: a comparison of selective serotonin reuptake inhibitors and tricyclic antidepressants

  1997cited by this paper
• Effects of selective serotonin reuptake inhibitors on platelet serotonin parameters in major depressive disorder.

  1997cited by this paper
• Prescription-event monitoring (PEM) in 1996-a method of non-interventional observational cohort pharmacovigilance.

  1997cited by this paper
• A comparison of fluvoxamine, fluoxetine, sertraline and paroxetine examined by observational cohort studies

  1997cited by this paper
• Pharmacological profile of antidepressants and related compounds at human monoamine transporters.

  1997cited by this paper
• Subhyaloid haemorrhage with fluoxetine

  1996cited by this paper
• Cross sectional database analysis of antidepressant prescribing in general practice in the United Kingdom, 1993–5

  1996cited by this paper
• Effects of Serotonin Reuptake Inhibitors on Hemostasis

  1996cited by this paper
• Bruising Associated with the Use of Fluoxetine

  1996cited by this paper
• Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors.

  1996cited by this paper
• Serotonin receptor specificity in anxiety disorders.

  1996cited by this paper
• Fluoxetine and hemostatic function: a pilot study.

  1995cited by this paper
• Serotonergic markers in platelets of patients with major depression: upregulation of 5-HT2 receptors.

  1995cited by this paper
• Pharmacology of antidepressants--characteristics of the ideal drug.

  1994cited by this paper
• Serotonin and the neurobiology of depression. Effects of tryptophan depletion in drug-free depressed patients.

  1994cited by this paper
• Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter.

  1994cited by this paper
• Bleeding attributed to the intake of paroxetine.

  1994cited by this paper
• Psychiatric status and 9-year mortality data in the New Haven Epidemiologic Catchment Area Study.

  1994cited by this paper
• Adverse events and treatment discontinuations in fluoxetine clinical trials

  1993cited by this paper
• Bleeding, a side effect of fluoxetine.

  1992cited by this paper
• Adverse vascular effects associated with fluoxetine.

  1992cited by this paper
• The clinical importance of acquired abnormalities of platelet function.

  1991cited by this paper
• Fluoxetine and bleeding in obsessive-compulsive disorder.

  1991cited by this paper
• Fluoxetine and the bleeding time.

  1990cited by this paper
• Agonist and antagonist activities of arylpiperazines at human platelet serotonin2 receptors.

  1988cited by this paper
• The effects of benzodiazepines and serotonergic manipulations on punished responding.

  1979cited by this paper
• Biogenic amines and depression. Biochemical and pharmacological separation of two types of depression.

  1975cited by this paper

• Effects of selective serotonin reuptake inhibitors on platelet functions: a literature review

  2024cites this paper
• Evaluation of Bleeding in Orthopedic Surgery With Perioperative Use of Serotonergic Antidepressants

  2022cites this paper
• Bleeding risk under selective serotonin reuptake inhibitor (SSRI) antidepressants: A meta‐analysis of observational studies

  2017cites this paper
• Prescription–Event Monitoring (PEM): The Evolution to the New Modified PEM and its Support of Risk Management

  2014cites this paper
• Effects of escitalopram in prevention of depression in patients with acute coronary syndrome (DECARD).

  2012cites this paper
• Early Steps in the Development of a Claims-Based Targeted Healthcare Safety Monitoring System and Application to Three Empirical Examples

  2012cites this paper
• Bleeding adverse drug reactions (ADRs) in patients exposed to antiplatelet plus serotonin reuptake inhibitor drugs: analysis of the French Spontaneous Reporting Database for a controversial ADR

  2012cites this paper
• Applied proteomics : using the peripheral proteome to identify a surrogate marker of schizophrenia

  2012cites this paper
• Down-regulation of the serotonin transporter in hyperreactive platelets counteracts the pro-thrombotic effect of serotonin.

  2012cites this paper
• Antidepressants and the risk of abnormal bleeding during spinal surgery: a case–control study

  2012cites this paper
• Monoamine depletion by reuptake inhibitors

  2011cites this paper
• SSRI-induced coagulopathy: is it reality?

  2011cites this paper
• The importance of drug–drug interactions as a cause of adverse drug reactions: a pharmacovigilance study of serotoninergic reuptake inhibitors in France

  2011cites this paper
• Selective Serotonin Reuptake Inhibitors and Gastrointestinal Bleeding: A Case-Control Study

  2011cites this paper
• Effects of Selective Serotonin Reuptake Inhibitors on Platelet Function

  2011cites this paper
• Use of Serotonergic Drugs and the Risk of Bleeding

  2011cites this paper
• The use of antidepressants and the risk of haemorrhagic stroke: a nested case control study.

  2011cites this paper
• Selective serotonin reuptake inhibitors and oral bleeding complications after invasive dental treatment.

  2011cites this paper
• Blutungsrisiko unter SSRI-Behandlung

  2010cites this paper
• Use of Serotonergic Antidepressants and Bleeding Risk in Orthopedic Patients

  2010cites this paper
• Risk of Ischemic Stroke Associated With Antidepressant Drug Use in Elderly Persons

  2010cites this paper
• Information about ADRs explored by pharmacovigilance approaches: a qualitative review of studies on antibiotics, SSRIs and NSAIDs

  2009cites this paper
• Preadmission use of SSRIs alone or in combination with NSAIDs and 30-day mortality after peptic ulcer bleeding

  2009cites this paper
• Screening for Depression in Adults and Older Adults in Primary Care

  2009cites this paper
• Mood Disorders in Later Life

  2008cites this paper
• Moderate and high affinity serotonin reuptake inhibitors increase the risk of upper gastrointestinal toxicity

  2008cites this paper
• Risk of Cerebrovascular Events Associated with Antidepressant Use in Patients with Depression: A Population-Based, Nested Case-Control Study

  2008cites this paper
• Tolerability of Selective Serotonin Reuptake Inhibitors

  2008cites this paper
• 1 Information about ADRs explored by pharmacovigilance approaches : a qualitative review of studies on antibiotics , SSRIs and NSAIDs

  2008cites this paper
• Risk of upper gastrointestinal tract bleeding associated with selective serotonin reuptake inhibitors and venlafaxine therapy: interaction with nonsteroidal anti-inflammatory drugs and effect of acid-suppressing agents.

  2008cites this paper
• Risk of Upper Gastrointestinal Bleeding and the Degree of Serotonin Reuptake Inhibition by Antidepressants

  2008cites this paper
• The Risk of Postpartum Hemorrhage With Selective Serotonin Reuptake Inhibitors and Other Antidepressants

  2008cites this paper
• Clinical impact of selective serotonin reuptake inhibitors therapy with bleeding risks

  2007cites this paper
• Antidepressant prophylaxis for poststroke depression: a meta-analysis

  2007cites this paper
• Influence of antidepressants on hemostasis

  2007cites this paper
• Potential medical and surgical complications of serotonergic antidepressant medications.

  2007cites this paper
• SSRIs & the risk of abnormal bleeding.

  2007cites this paper
• Bruising associated with sibutramine: results from postmarketing surveillance in New Zealand

  2006cites this paper
• Maternal Selective Serotonin Reuptake Inhibitor Intake Does Not Seem to Affect Neonatal Platelet Function Tests

  2006cites this paper
• Antiplatelet Activity During Coadministration of the Selective Serotonin Reuptake Inhibitor Paroxetine and Aspirin in Male Smokers: A Randomized, Placebo‐Controlled, Double‐blind Trial

  2006cites this paper
• Antidepressants and risk of upper gastrointestinal bleeding.

  2006cites this paper
• Effect of Selective Serotonin Reuptake Inhibitors on Requirement for Allogeneic Red Blood Cell Transfusion Following Coronary Artery Bypass Surgery

  2006cites this paper
• Selective serotonin reuptake inhibitors and risk of upper GI bleeding: confusion or confounding?

  2006cites this paper
• SSRIs and Upper Gastrointestinal Bleeding

  2006cites this paper
• Which patients taking SSRIs are at greatest risk of bleeding?

  2006cites this paper
• Increased use of selective serotonin reuptake inhibitors in patients admitted with gastrointestinal haemorrhage: a multicentre retrospective analysis

  2006cites this paper
• Re: Lorazepam-Induced Prolongation of the QT Interval in a Patient with Schizoaffective Disorder and Complete AV Block

  2005cites this paper
• Hemorrhages during Escitalopram—Venlafaxine— Mirtazapine Combination Treatment of Depression

  2005cites this paper
• Depression, alterations in platelet function, and ischemic heart disease.

  2005cites this paper
• Selective serotonin re-uptake inhibitors and the risk of bleeding

  2005cites this paper
• Is it safe to use antidepressants after a stroke?

  2005cites this paper
• SSRIs and gastrointestinal bleeding

  2005cites this paper
• Cerebrovascular effects of selective serotonin reuptake inhibitors: a systematic review.

  2004cites this paper
• Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants.

  2004cites this paper
• Platelet hyperactivity in clinical depression and the beneficial effect of antidepressant drug treatment: how strong is the evidence?

  2004cites this paper
• Do SSRIs cause gastrointestinal bleeding?

  2004cites this paper
• Antidepressive Medikation bei Patienten mit kardiovaskulären Erkrankungen

  2004cites this paper
• Current Use of Selective Serotonin Reuptake Inhibitors and Risk of Acute Myocardial Infarction

  2004cites this paper
• Relationship of serotonergic antidepressants and need for blood transfusion in orthopedic surgical patients.

  2003cites this paper
• Platelets and anti-platelet therapy.

  2003cites this paper
• Effect of Selective Serotonin Reuptake Inhibitors on Platelet Activation

  2003cites this paper
• A unique central tryptophan hydroxylase isoform.

  2003cites this paper
• Utilisation and Safety of Low Molecular Weight Heparins

  2003cites this paper
• PHARMACOEPIDEMIOLOGY AND PRESCRIPTION

  2003cites this paper
• A critical review of selective serotonin reuptake inhibitor-associated bleeding: balancing the risk of treating hepatitis C-infected patients.

  2003cites this paper
• Sertraline for social anxiety disorder

  2003cites this paper
• Use of selective serotonin reuptake inhibitors and the risk of stroke: is there reason for concern?

  2002cites this paper
• Use of selective serotonin reuptake inhibitors and myocardial infarction.

  2002cites this paper
• Pharmacoepidemiology and drug safety

  2001cites this paper
• Current Awareness

  2001cites this paper